Aurobindo Pharma Ltd has announced that the Company has received approval from the USFDA for Amlodipine Besylate Tablets 2.5 mg, 5 mg & 10 mg. This is the Companys fifth anti-hypertensive approval from USFDA.
Amlodipine Besylate Tablets 2.5 mg, 5 mg & 10 mg are the Generic equivalent of Pfizers Norvasc® Tablets and are indicated for the treatment of hypertension. The brand product has approximately annual sales of USD 2.8 billion.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment